Close Menu

NEW YORK – Aspira Women's Health announced on Wednesday that it was planning a private equity financing of around $11 million.

The Austin, Texas-based firm, formerly known as Vermillion, said that investors, including affiliates of the former President and COO of Abbott Laboratories, Jack Schuler, the company's largest stockholder, had agreed to purchase approximately $11 million of unregistered shares of Aspira common stock in a private placement at a price of $3.50 per share.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.